National / Science & Health May 13, 2020
A tale of two Japanese drugs in tests to fight COVID-19
by Rocky Swift and Christine Soares
Avigan and camostat are undergoing trials as they may be effective in treating illnesses brought on by coronavirus.
A tale of two Japanese drugs in tests to fight COVID-19
Avigan and camostat are undergoing trials as they may be effective in treating illnesses brought on by coronavirus.
Abe follows Trump's example, approving drugs quickly after criticism
Japanese regulators are usually known for taking a year to approve new drugs, but authorized remdesivir just three days after receiving the application.
Drugmaker Shionogi rushing to launch coronavirus vaccine in 2021
It is rare to study production before getting the results of clinical trials, but the Japanese drugmaker wants a vaccine on the market as fast as possible.
U.S. emergency approval broadens use of Gilead's COVID-19 drug remdesivir
Gilead Science Inc.'s antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday, clearing the way for broader use of the drug in more hospitals around the United States. During a meeting in the Oval Office ...
Virus drugmaker caught between making a profit and treating the world
Gilead Sciences Inc. may spend $1 billion on its breakthrough new treatment for COVID-19 this year alone, Chief Executive Officer Daniel O’Day said. How much revenue — if any — the company expects to generate is another matter. Details from a U.S. government study and ...
Remdesivir drug to be approved for coronavirus patients in May
This is the first time the government has used the streamlined process since the pandemic started.
Shionogi to develop coronavirus vaccine, with trials eyed for this year
Shionogi & Co. said Monday it will develop a vaccine for the novel coronavirus with the aim of starting clinical trials this year. The Osaka-based company has decided to develop a recombinant protein vaccine through its subsidiary UMN Pharma Inc. while also seeking to discover ...
Countries and companies risk billions in race for coronavirus vaccine
Governments, charities and Big Pharma firms are making huge bets with extraordinarily low odds of success.
Official says he was ousted for urging caution on Trump-touted virus drug
The ousted director of a key U.S. agency charged with developing drugs to fight the COVID-19 pandemic said Wednesday he was dismissed because he called for careful vetting of a treatment frequently touted by President Donald Trump. Rick Bright said in a statement that he ...
Abe touts Avigan as COVID-19 treatment despite experts urging caution
Medical experts warn the drug, also known as favipiravir, may cause birth defects and it cannot be administered to expecting mothers or those who may become pregnant.
Hydroxychloroquine, championed by Trump for virus, may raise death risk
An old malaria drug touted by U.S. President Donald Trump as a "game changer" in the fight against the coronavirus provided no benefit and potentially higher risk of death for patients at U.S. veterans hospitals, according to an analysis that has been submitted for ...
Fujifilm to boost capacity to make COVID-19 treatment Avigan
Fujifilm Holdings Corp. said Wednesday it has expanded manufacturing capacity to "significantly increase" production of its anti-flu drug Avigan that is being tested as a treatment for COVID-19. Fujifilm expects to increase the production of Avigan up to 100,000 treatment courses by July 2020, about ...